Boustead buys entire WhiteRock medical group for S$19m
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
BOUSTEAD Singapore announced on Thursday it has entered into a sale-and-purchase agreement with WhiteRock Medical Company (WhiteRock MedCo) to fully acquire WhiteRock Incorporation (WRI), a group of 16 healthcare corporations operating in Singapore, China, Hong Kong, Malaysia and Thailand, for S$19.02 million.
Boustead said the acquisition's value was arrived at after taking into account WRI's adjusted unaudited net asset value and net tangible asset value, as well as its historical financial performance and future business prospects.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result